Skip to menu Skip to content Skip to footer

2020

Conference Publication

Anticancer activity of the taxane nanoparticles, DEP® docetaxel and DEP® cabazitaxel

Kelly, Brian D., McLeod, Victoria, Walker, Rachael, Schreuders, Jeannette, Jackson, Susan, Giannis, Michael, Dietinger, Christine, Reitano, Pauline, Pathak, Rashmi, Xia, Shirley, Cargill, Anne, Seta, Aynaz, Hufton, Richard, Heery, Graham, Cullinane, Carleen and Owen, David J. (2020). Anticancer activity of the taxane nanoparticles, DEP® docetaxel and DEP® cabazitaxel. AACR Annual Meeting 2020, Philadelphia, PA United States, 27-28 April 2020. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2020-1716

Anticancer activity of the taxane nanoparticles, DEP® docetaxel and DEP® cabazitaxel

2020

Conference Publication

Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models

Kelly, Brian D., McLeod, Victoria, Walker, Rachael, Schreuders, Jeannette, Jackson, Susan, Giannis, Michael, Dietinger, Christine, Xia, Shirley, Cargill, Anne, Seta, Aynaz, Hufton, Richard, Heery, Graham, Cullinane, Carleen and Owen, David J. (2020). Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models. AACR Annual Meeting 2020, Philadelphia, PA United States, 27-28 April 2020. Philadelphia, PA United States: American Association for Cancer Research (AACR). doi: 10.1158/1538-7445.am2020-1715

Anti-cancer activity of a SN-38 nanoparticle, DEP® irinotecan, in human colon cancer xenograft models

2020

Conference Publication

Design and optimization of a dendrimer-conjugated dual Bcl-2/Bcl-xL inhibitor, AZD0466, with improved therapeutic index

Ashford, Marianne B., Balachander, Srividya B., Graham, Lorraine, Grant, Iain, Gibbons, Francis D., Hill, Kathryn J., Harmer, Alexander R., Gales, Sonya, Redmond, Sean, Kelly, Brian, McCoull, William, Wen, Shenghua, Wild, Martin, Gangl, Eric, Owen, David J. and Davies, Barry R. (2020). Design and optimization of a dendrimer-conjugated dual Bcl-2/Bcl-xL inhibitor, AZD0466, with improved therapeutic index. AACR Annual Meeting 2020, Philadelphia, PA United States, 27-28 April 2020. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2020-1718

Design and optimization of a dendrimer-conjugated dual Bcl-2/Bcl-xL inhibitor, AZD0466, with improved therapeutic index